Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Guy A. Cabral, Thomas J. Rogers, Aron H. Lichtman
Journal of Neuroimmune Pharmacology (2015) Vol. 10, Iss. 2, pp. 193-203
Open Access | Times Cited: 133

Showing 26-50 of 133 citing articles:

The (endo)cannabinoid signaling in female reproduction: What are the latest advances?
Sandra Cecconi, Cinzia Rapino, Valentina Di Nisio, et al.
Progress in Lipid Research (2019) Vol. 77, pp. 101019-101019
Closed Access | Times Cited: 35
FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats
Lisa E. Flannery, Daniel M. Kerr, David P. Finn, et al.
Behavioural Brain Research (2018) Vol. 353, pp. 11-20
Open Access | Times Cited: 32
Cannabidiol affects circadian clock core complex and its regulation in microglia cells
Geneviève Lafaye, Christophe Desterke, Laurent Marulaz, et al.
Addiction Biology (2018) Vol. 24, Iss. 5, pp. 921-934
Closed Access | Times Cited: 32
Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015–2019)
Erinn C. Cameron, Samantha L. Hemingway
Journal of Cannabis Research (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 30
Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours
Sarah Dada, Samantha L. S. Ellis, Christi L. Wood, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 10
Cannabinoids and the Microbiota–Gut–Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders
Hollis C. Karoly, Raeghan L. Mueller, L. Cinnamon Bidwell, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 44, Iss. 2, pp. 340-353
Closed Access | Times Cited: 29
Nuclear Lipids in the Nervous System: What they do in Health and Disease
Mercedes Garcia‐Gil, Elisabetta Albi
Neurochemical Research (2016) Vol. 42, Iss. 2, pp. 321-336
Closed Access | Times Cited: 27
Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice
Geraint Berger, Nipun Arora, Ian Burkovskiy, et al.
Molecules (2019) Vol. 24, Iss. 23, pp. 4239-4239
Open Access | Times Cited: 27
Cannabis and Autoimmunity: Possible Mechanisms of Action
Valeria Giorgi, Daniela Marotto, Alberto Batticciotto, et al.
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 261-271
Open Access | Times Cited: 20
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
Lirit N. Franks, Benjamin M. Ford, Paul L. Prather
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 25
Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
Beatriz Correia, Joana Fernandes, Maria João Botica, et al.
Medicines (2022) Vol. 9, Iss. 3, pp. 19-19
Open Access | Times Cited: 13
Antibacterial Effects of Phytocannabinoids
Cassidy Scott, Daniel Neira Agonh, Christine Lehmann
Life (2022) Vol. 12, Iss. 9, pp. 1394-1394
Open Access | Times Cited: 13
Health benefits, pharmacological properties, and metabolism of cannabinol: A comprehensive review
Aya Khouchlaa, Sara Khouri, Ahmed Hajib, et al.
Industrial Crops and Products (2024) Vol. 213, pp. 118359-118359
Open Access | Times Cited: 2
Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation
Julie T. Castaneda, Airi Harui, Michael D. Roth
Journal of Neuroimmune Pharmacology (2017) Vol. 12, Iss. 3, pp. 544-554
Open Access | Times Cited: 24
Marijuana use should not preclude consideration for kidney transplantation
Kassandra Fabbri, Tracy Anderson-Haag, Anne M. Spenningsby, et al.
Clinical Transplantation (2019) Vol. 33, Iss. 10
Closed Access | Times Cited: 22
Using Cannabis to Treat Cancer-Related Pain
Timothy Byars, Eloise Theisen, Deborah L. Bolton
Seminars in Oncology Nursing (2019) Vol. 35, Iss. 3, pp. 300-309
Closed Access | Times Cited: 20
Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement
Bradford P. Whitcomb, Christopher V. Lutman, Michael L. Pearl, et al.
Gynecologic Oncology (2020) Vol. 157, Iss. 2, pp. 307-311
Closed Access | Times Cited: 20
Microbiomic differences at cancer-prone oral mucosa sites with marijuana usage
Taylor Newman, Laya P. Krishnan, Jessica Lee, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Characterization of CB2 Receptor Expression in Peripheral Blood Monocytes of Acute Ischemic Stroke Patients
Rosaria Greco, Chiara Demartini, Annamaria Zanaboni, et al.
Translational Stroke Research (2020) Vol. 12, Iss. 4, pp. 550-558
Closed Access | Times Cited: 16
Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis
William Becker, Haider Rasheed Alrafas, Philip Brandon Busbee, et al.
Journal of Crohn s and Colitis (2020) Vol. 15, Iss. 6, pp. 1032-1048
Open Access | Times Cited: 16
Systematic Affinity Purification Coupled to Mass Spectrometry Identified p62 as Part of the Cannabinoid Receptor CB2 Interactome
Ahmed Sharaf, Leonore Mensching, Christina Keller, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 17
Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis
Ting Zhou, Tina Khorshid Ahmad, Samaa Alrushaid, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 516, Iss. 2, pp. 373-380
Closed Access | Times Cited: 16
Potential of cannabinoids as treatments for autism spectrum disorders
Vera Nezgovorova, Casara Jean Ferretti, Bonnie P. Taylor, et al.
Journal of Psychiatric Research (2021) Vol. 137, pp. 194-201
Open Access | Times Cited: 14
Increased markers of inflammation after cannabis cessation and their association with psychotic symptoms
Bruno Roméo, Valentine Lestra, Catherine Martelli, et al.
Acta Neuropsychiatrica (2023) Vol. 36, Iss. 2, pp. 118-127
Closed Access | Times Cited: 5
FAAH, but not MAGL, inhibition modulates acute TLR3‐induced neuroimmune signaling in the rat, independent of sex
Lisa E. Flannery, Rebecca J. Henry, Daniel M. Kerr, et al.
Journal of Neuroscience Research (2017) Vol. 96, Iss. 6, pp. 989-1001
Open Access | Times Cited: 15

Scroll to top